SCHEMBL7302928

SCHEMBL7302928

O=C1c2ccccc2S(=O)(=O)N1CS(=O)(=O)c1ncccn1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 11/20 0.54
CA9 Q16790 10/20 0.54
ELANE P08246 1/20 0.54
CA2 P00918 4/20 0.54
USP2 O75604 1/20 0.52
HTR1A P08908 2/20 0.49
ABCB11 O95342 1/20 0.49
ALDH1A1 P00352 1/20 0.49
CYP1A2 P05177 1/20 0.49
ADRA2A P08913 1/20 0.49
CYP2D6 P10635 1/20 0.49
DRD2 P14416 1/20 0.49
ADRA2B P18089 1/20 0.49
ADRA2C P18825 1/20 0.49
DRD4 P21917 1/20 0.49
ADRA1D P25100 1/20 0.49
HTR2A P28223 1/20 0.49
CYP2C19 P33261 1/20 0.49
HTR7 P34969 1/20 0.49
ADRA1A P35348 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7420571 0.81 CA12 (0.61) CA12CA9ELANECA2CYP2D6
SCHEMBL7307976 0.77 ELANE (0.56) CA12CA9ELANECA2
SCHEMBL7312653 0.73 ELANE (0.58) CA12CA9ELANECA2USP2
SCHEMBL7309421 0.72 CA12 (0.54) CA12CA9ELANECA2USP2
SCHEMBL6958970 0.72 CA12 (0.71) CA12CA9ELANECA2
SCHEMBL11600621 0.71 TDP1 (0.76) CA12CA9CA2USP2ALDH1A1
SCHEMBL1101896 0.71 CA12 (1.00) CA12CA9ELANECA2ALDH1A1
SCHEMBL7290946 0.71 CA12 (0.69) CA12CA9ELANECA2
SCHEMBL5899155 0.71 ELANE (1.00) CA12CA9ELANECA2
SCHEMBL356403 0.71 CA12 (0.69) CA12CA9ELANECA2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5874432-A Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof SANOFI (FR) 1999-02-23 US disclosed
EP-0471756-B1 SACCHARIN DERIVATIVES USEFUL AS PROTEOLYTIC ENZYME INHIBITORS AND PREPARATION THEREOF SANOFI SA (FR) 1997-10-29 EP disclosed
US-5650422-A TREATMENT OF EMPHYSEMA, ARTHRITIS OR PANCREATITIS SANOFI (FR) 1997-07-22 US disclosed
US-5596012-A Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof STERLING WINTHROP INC. (US) 1997-01-21 US disclosed
US-5371074-A Use of saccharin derivatives as proteolytic enzyme inhibitors STERLING WINTHROP INC. (US) 1994-12-06 US disclosed
US-5236917-A Respiratory system disorders, antiarthritic agents STERLING WINTHROP INC. (US) 1993-08-17 US disclosed
EP-0542372-A1 2-Substituted saccharin derivative proteolytic enzyme inhibitors STERLING WINTHROP INC. (US) 1993-05-19 EP disclosed
EP-0471756-A4 SACCHARIN DERIVATIVES USEFUL AS PROTEOLYTIC ENZYME INHIBITORS AND PREPARATION THEREOF 1992-04-08 EP disclosed
EP-0471756-A1 SACCHARIN DERIVATIVES USEFUL AS PROTEOLYTIC ENZYME INHIBITORS AND PREPARATION THEREOF. STERLING WINTHROP INC (US) 1992-02-26 EP disclosed
WO-1990013549-A1 SACCHARIN DERIVATIVES USEFUL AS PROTEOLYTIC ENZYME INHIBITORS AND PREPARATION THEREOF STERLING WINTHROP INC. (US) 1990-11-15 WO disclosed